Drug Profile
PEN 203
Alternative Names: PapirineLatest Information Update: 29 May 2007
Price :
$50
*
At a glance
- Originator Cambrex Corporation; CoPharma
- Developer CoPharma
- Class Antivirals
- Mechanism of Action Immunostimulants; Ribonuclease stimulants; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpesvirus infections; Human papillomavirus infections